GB2051574B - Adjuvant for promoting absorption of pharmacologically active substances through the rectum - Google Patents

Adjuvant for promoting absorption of pharmacologically active substances through the rectum

Info

Publication number
GB2051574B
GB2051574B GB8015044A GB8015044A GB2051574B GB 2051574 B GB2051574 B GB 2051574B GB 8015044 A GB8015044 A GB 8015044A GB 8015044 A GB8015044 A GB 8015044A GB 2051574 B GB2051574 B GB 2051574B
Authority
GB
United Kingdom
Prior art keywords
rectum
adjuvant
active substances
pharmacologically active
promoting absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8015044A
Other languages
English (en)
Other versions
GB2051574A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyoto Pharmaceutical Industries Ltd
Original Assignee
Kyoto Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5769079A external-priority patent/JPS55149209A/ja
Priority claimed from JP55035128A external-priority patent/JPS5857407B2/ja
Application filed by Kyoto Pharmaceutical Industries Ltd filed Critical Kyoto Pharmaceutical Industries Ltd
Publication of GB2051574A publication Critical patent/GB2051574A/en
Application granted granted Critical
Publication of GB2051574B publication Critical patent/GB2051574B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB8015044A 1979-05-10 1980-05-06 Adjuvant for promoting absorption of pharmacologically active substances through the rectum Expired GB2051574B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5769079A JPS55149209A (en) 1979-05-10 1979-05-10 Composition for rectal administration
JP55035128A JPS5857407B2 (ja) 1980-03-19 1980-03-19 直腸投与剤用基剤

Publications (2)

Publication Number Publication Date
GB2051574A GB2051574A (en) 1981-01-21
GB2051574B true GB2051574B (en) 1984-01-18

Family

ID=26374052

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8015044A Expired GB2051574B (en) 1979-05-10 1980-05-06 Adjuvant for promoting absorption of pharmacologically active substances through the rectum

Country Status (5)

Country Link
US (2) US4338306A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1166964A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3017829A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2455897A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2051574B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
JPS55153712A (en) * 1979-05-18 1980-11-29 Kao Corp Insulin pharmaceutical preparation and its production
US4442090A (en) * 1980-11-09 1984-04-10 Kyoto Yakuhin Kogyo Kabushiki Kaisha Absorption-promoting compounds, compositions thereof with pharmaceuticals and/or bases for rectal administration and method of use
SE460638B (sv) * 1981-01-14 1989-11-06 Toyo Jozo Kk Suppositoriepreparat med foerbaettrad absorptionsegenskap
DE3250023T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1981-01-14 1990-03-29
FR2509175B1 (fr) * 1981-03-06 1987-01-16 Toyo Jozo Kk Preparation therapeutique ayant d'excellentes proprietes d'absorption
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
CA1256799A (en) * 1984-02-22 1989-07-04 Walter Fuller Suppositories
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
DK158598C (da) * 1988-07-07 1990-11-19 Pharma Vinci As Penicillinpraeparat til rektal administration
US5190748A (en) * 1988-11-22 1993-03-02 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
WO1990009385A1 (en) * 1989-02-17 1990-08-23 The Liposome Company, Inc. Lipid excipient for nasal delivery and topical application
DD293488A5 (de) * 1989-02-22 1991-09-05 Berlin-Chemie Ag, Verfahren zur herstellung von arzneimitteln zur rektalen applikation
EP0420056B1 (en) * 1989-09-27 1994-01-12 Universiteit Gent Use of fatty acids, fatty acid salts and fatty acid esters of mono-, di- or trihydroxy alkanes
WO1992014479A1 (en) * 1991-02-19 1992-09-03 Tsumura & Co. Composition for rectal administration of difficultly absorbable peptide
WO1993008804A1 (en) * 1991-11-08 1993-05-13 Kyoto Pharmaceutical Industries, Ltd. Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration
US5891435A (en) * 1993-04-16 1999-04-06 Research Corporation Technologies, Inc. Methods and compositions for delaying or preventing the onset of autoimmune disease
EP0800828A4 (en) * 1994-12-28 1999-03-31 Teikoku Hormone Mfg Co Ltd TRANSMUCOSAL PREPARATION
US7169889B1 (en) * 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
EP1346726A4 (en) * 2000-12-25 2004-09-15 Shiseido Co Ltd Sympathetic-activating perfume composition
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6867183B2 (en) * 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
AT413015B (de) * 2001-04-12 2005-10-15 Sandoz Ag Tablette enthaltend das k-salz der 3-(2-hydroxyethyliden)-7-oxo-4-oxa-1- azabicyclo(3.2.0)heptan-2 carbonsäure in hydrophobisierter form
WO2002083129A2 (en) * 2001-04-12 2002-10-24 Sandoz Gmbh Pharmaceutical composition comprising clavulanic acid
US6828305B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6913903B2 (en) 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6770625B2 (en) * 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
US7166571B2 (en) * 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6585996B1 (en) 2002-03-13 2003-07-01 Westlake Laboratories, Inc. Lipid-soluble thiamine derivatives in the treatment of autism
US7601688B2 (en) * 2002-06-13 2009-10-13 Biocon Limited Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
US20050232981A1 (en) * 2004-04-15 2005-10-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
RU2393168C2 (ru) * 2004-07-19 2010-06-27 Биокон Лимитед Инсулин-олигомерные конъюгаты, их препараты и применения
EP1934252B1 (en) * 2005-10-13 2015-06-24 Biocon Limited Process for the preparation of insulin conjugates.
PT2203181T (pt) 2007-10-16 2018-05-10 Biocon Ltd Uma composição farmacêutica sólida para administração por via oral e o seu processo de fabrico
US20090271021A1 (en) * 2008-04-28 2009-10-29 Popp Shane M Execution system for the monitoring and execution of insulin manufacture
LT2343982T (lt) 2008-09-17 2017-07-25 Chiasma Inc. Farmacinės kompozicijos ir susiję pateikimo būdai
SI24318A (sl) * 2013-03-13 2014-09-30 Diagen D.O.O. Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji
WO2016126830A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
WO2018087298A1 (en) * 2016-11-14 2018-05-17 University Of Copenhagen Rectal insulin for treatment of inflammatory bowel diseases
CA3052047A1 (en) 2017-02-13 2018-08-16 Wintermute Biomedical, Inc. Anti-pathogenic therapeutic compositions
CN113164420B (zh) 2018-10-01 2025-01-03 温特穆特生物医学公司 治疗组合物
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL45481C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1900-01-01
US1499348A (en) * 1918-09-03 1924-07-01 Frederick D Crane Suppository and method of making the same
US2241331A (en) * 1939-01-27 1941-05-06 Wm S Merrell Co Suppository
US2870201A (en) * 1955-04-04 1959-01-20 Maxwell A Pollack Synthesis of amino acids
GB792559A (en) * 1955-07-12 1958-03-26 Glaxo Lab Ltd Improvements in or relating to the manufacture of veterinary preparations containing penicillin
US2854378A (en) * 1955-12-08 1958-09-30 Bristol Lab Inc Tetracycline suppository
DE1094930B (de) * 1959-04-24 1960-12-15 Dehydag Gmbh Verfahren zur Herstellung von Suppositorien
FR2853M (fr) * 1963-02-20 1964-10-19 Roussel Uclaf Nouveau médicament, notamment pour le traitement des infections dues a des staphylocoques.
DE2211619A1 (de) * 1972-03-07 1973-09-20 Mannesmann Meer Ag Untersetzungsgetriebe mit leistungsverzweigung, insbesondere fuer den kippantrieb von stahlwerkskonvertern
FR2272684A1 (en) * 1975-01-07 1975-12-26 Ito Shojiro Antibiotic-unsaturated acid compsns. - having a synergistic effect against gram positive and negative bacteria
DE2700433A1 (de) * 1977-01-07 1978-07-20 Kali Chemie Pharma Gmbh Arzneimittelzubereitungen mit verbesserten resorptionseigenschaften
JPS5391113A (en) * 1977-01-21 1978-08-10 Meiji Seika Kaisha Ltd Preparation of suppository of antibiotics
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS6029535B2 (ja) * 1977-03-12 1985-07-11 ロ−ト製薬株式会社 塑性体成形組成物の製造法
US4331653A (en) * 1977-08-18 1982-05-25 Robert Brown Composition for a topical cream for curtailing bleeding and treating skin disorders
FR2427100A1 (fr) * 1978-06-02 1979-12-28 Kali Chemie Pharma Gmbh Composition pharmaceutique a propriete de resorption amelioree et procede pour sa fabrication
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum

Also Published As

Publication number Publication date
FR2455897B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1985-03-01
FR2455897A1 (fr) 1980-12-05
US4485033A (en) 1984-11-27
US4338306A (en) 1982-07-06
GB2051574A (en) 1981-01-21
DE3017829C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-07-07
DE3017829A1 (de) 1980-11-20
CA1166964A (en) 1984-05-08

Similar Documents

Publication Publication Date Title
GB2051574B (en) Adjuvant for promoting absorption of pharmacologically active substances through the rectum
GB2061726B (en) Furocoumarin for the photochemotherapy of psoriasis
AU509784B2 (en) Liquid absorption pad
ZA776129B (en) Pharmaceutically active compounds
PT66301B (en) Pharmacologically active polyphenolic substances
IT1142135B (it) Polietilenimmina impiegata per l'assorbimento di sostanze alfattivamente attive
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
EG16606A (en) Therapeutic agents
ZA804514B (en) Pharmacologically active substituted 3-amino-sydnone-imines processes for their preparation and their use
JPS56100347A (en) Laserrexpanded xxray absorption fineestructure
ZA765331B (en) Novel pharmaceutically active compounds
NO834729L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tio-cefalosporiner
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
PH16726A (en) Absorbent structure
NO830900L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
ZA761324B (en) Pharmaceutically active compounds
NO813263L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater
NO832329L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tricykliske forbindelser.
NO834437L (no) Fremgangsmaate for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.
NO152843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidopyrimidiner.
GB2082936B (en) Materials suitable for the absorption of sound
ZA794209B (en) Pharmaceutically active heterocyclic compounds

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20000505